Atlantic Canadian companies investing in genomics

Published: June 26th 2018

Business Expenditure on Research & Development (BERD) is an important indicator for economic growth. Atlantic Canadian companies are investing significantly in genomics R&D, explains Genome Atlantic President & CEO Steve Armstrong, in a Letter published in The Telegram (St. John’s, NL) and The Chronicle Herald (Halifax, NS).